On ECHEMI
Home > Drugs > Urinary tract infection
Urinary tract infection
Urinary tract infection (UTI) refers to the inflammation caused by the growth and reproduction of pathogens in the urinary tract and the invasion of the urinary tract mucosa or tissue. It is the most common type of bacterial infection. Urinary tract infection is divided into upper urinary tract infection and lower urinary tract infection. Upper urinary tract infection refers to pyelonephritis, and lower urinary tract infection includes urethritis and cystitis. According to the presence or absence of underlying diseases, urinary tract infection can also be divided into complicated urinary infection and uncomplicated urinary infection. Pyelonephritis is further divided into acute pyelonephritis and chronic pyelonephritis. It is more common in women. Its clinical manifestations are often: acute urethral syndrome, chronic urethral syndrome, asymptomatic bacteriuria, renal abscess and perinephric abscess. Among them, urinary tract infections caused by different pathogens include: chlamydial urinary tract infection, mycoplasma urinary tract infection, fungal urinary tract infection, and parasitic urinary tract infection. Urinary tract infections in different populations include: menopausal urinary tract infection, pediatric urinary tract infection, elderly urinary tract infection, postpartum urinary tract infection, and pregnancy urinary tract infection.
Related Drugs
Trimethoprim-sulfamethoxazole capsules
Indication: It is mainly used for urinary tract infections, intestinal infections, acute attacks of chronic bronchitis in adults, acute otitis media, etc. caused by bacteria sensitive to this product.
Manufacturer:

China Resources 39 (Beijing) Pharmaceutical Co., Ltd.

Trimethoprim-sulfamethoxazole capsules
Indication: It is mainly used for urinary tract infections, intestinal infections, acute attacks of chronic bronchitis in adults, acute otitis media, etc. caused by bacteria sensitive to this product.
Manufacturer:

North China Pharmaceutical Hebei Huanuo Co., Ltd.

Compound Sulfamethoxazole Capsules
Indication: 1. The main indication is urinary tract infection caused by sensitive strains of Escherichia coli, Klebsiella, Enterobacter, Proteus mirabilis, Proteus vulgaris and Morganella; 2. The main indication is acute otitis media in children over 2 years old caused by sensitive strains of Streptococcus pneumoniae or Haemophilus influenzae; 3. The main indication is acute exacerbation of chronic bronchitis in adults caused by sensitive strains of Streptococcus pneumoniae or Haemophilus influenzae; 4. The main indication is intestinal infection and Shigella infection caused by sensitive strains of Shigella flexneri or sonnei; 5. The main indication is the treatment of Pneumocystis carinii pneumonia caused by sensitive strains, and this product is the first choice; 6. The main indication is the prevention of Pneumocystis carinii pneumonia caused by sensitive strains, and it can be used
Manufacturer:

Tiansheng Pharmaceutical Group Co., Ltd.

Compound Sulfamethoxazole Capsules
Indication: The main indications of this product are the following infections caused by sensitive strains: 1. Urinary tract infections caused by sensitive strains of Escherichia coli, Klebsiella, Enterobacter, Proteus mirabilis, Proteus vulgaris and Morganella. 2. Acute otitis media in children over 2 years old caused by Streptococcus pneumoniae or Haemophilus influenzae. 3. Acute exacerbation of chronic bronchitis in adults caused by Streptococcus pneumoniae or Haemophilus influenzae. 4. Intestinal infections and Shigella infections caused by sensitive strains of Shigella flexneri or Shigella sonnei. 5. This product is the first choice for the treatment of Pneumocystis carinii pneumonia. 6. For the prevention of Pneumocystis carinii pneumonia, patients with a history of at least one attack of Pneumocystis carinii disease or HIV-infected adults with a CD4 lymphocyte count ≤ 200/mm3 or less than 20% of the total lymphocyte count can be used.
Manufacturer:

Tonghua Xinghua Pharmaceutical Co., Ltd.

Compound Sulfamethoxazole Capsules
Indication: The main indications of this product are the following infections caused by sensitive strains: 1. Urinary tract infections caused by sensitive strains of Escherichia coli, Klebsiella, Enterobacter, Proteus mirabilis, Proteus vulgaris and Morganella. 2. Acute otitis media in children over 2 years old caused by Streptococcus pneumoniae or Haemophilus influenzae. 3. Acute exacerbation of chronic bronchitis in adults caused by Streptococcus pneumoniae or Haemophilus influenzae. 4. Intestinal infections and Shigella infections caused by sensitive strains of Shigella flexneri or Shigella sonnei. 5. This product is the first choice for the treatment of Pneumocystis carinii pneumonia. 6. For the prevention of Pneumocystis carinii pneumonia, patients with a history of at least one attack of Pneumocystis carinii disease or HIV-infected adults with a CD4 lymphocyte count ≤ 200/mm3 or less than 20% of the total lymphocyte count can be used.
Manufacturer:

China Resources 39 (Beijing) Pharmaceutical Co., Ltd.

Flavonoid Hydrochloride Tablets
Indication: This product is suitable for symptoms such as frequent urination, urgent urination, painful urination, dysuria and urinary incontinence caused by the following diseases: 1. Lower urinary tract infectious diseases (prostatitis, cystitis, urethritis, etc.). 2. Lower urinary tract obstructive diseases (early and middle stage prostatic hyperplasia, spastic and functional urethral stricture). 3. After lower urinary tract instrument examination or surgery (prostatectomy, urethral dilation, intravesical surgery). 4. Urethral syndrome. 5. Urgent urinary incontinence.
Manufacturer:

Jilin Jinheng Pharmaceutical Co., Ltd.

Flavonoid Hydrochloride Tablets
Indication: This product is suitable for symptoms such as frequent urination, urgent urination, painful urination, dysuria and urinary incontinence caused by the following diseases: 1. Lower urinary tract infectious diseases (prostatitis, cystitis, urethritis, etc.). 2. Lower urinary tract obstructive diseases (early and middle stage prostatic hyperplasia, spastic and functional urethral stricture). 3. After lower urinary tract instrument examination or surgery (prostatectomy, urethral dilation, intravesical surgery). 4. Urethral syndrome. 5. Urgent urinary incontinence.
Manufacturer:

Zhuozhou Dongle Pharmaceutical Co., Ltd.

Flavonoid Hydrochloride Tablets
Indication: This product is suitable for symptoms such as frequent urination, urgent urination, painful urination, dysuria and urinary incontinence caused by the following diseases: 1. Lower urinary tract infectious diseases (prostatitis, cystitis, urethritis, etc.). 2. Lower urinary tract obstructive diseases (early and middle stage prostatic hyperplasia, spastic and functional urethral stricture). 3. After lower urinary tract instrument examination or surgery (prostatectomy, urethral dilation, intravesical surgery). 4. Urethral syndrome. 5. Urgent urinary incontinence.
Manufacturer:

Chengdu Brilliant Pharmaceutical Co., Ltd.

Flavonoid Hydrochloride Tablets
Indication: This product is suitable for the following diseases caused by frequent urination, urgent urination, painful urination, dysuria and urinary incontinence and other symptoms: 1. Lower urinary tract infectious diseases (prostatitis, cystitis, urethritis, etc.). 2. Lower urinary tract obstructive diseases (early and middle stage prostatic hyperplasia, spastic and functional urethral stricture). 3. After lower urinary tract instrument examination or surgery (prostatectomy, urethral dilation, intravesical surgery). 4. Urethral syndrome. 5. Urgent urinary incontinence.
Manufacturer:

Shenzhen Neptunus Pharmaceutical Co., Ltd.

Cefoperazone Sodium for Injection
Indication: It is suitable for various infections caused by sensitive bacteria such as pneumonia and other lower respiratory tract infections, urinary tract infections, biliary tract infections, skin and soft tissue infections, sepsis, peritonitis, pelvic infections, etc. The latter two should be used in combination with anti-anaerobic drugs.
Manufacturer:

Harbin Pharmaceutical Group Co., Ltd. GENERAL Pharm. FACTORY

Related Ingredients
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.